Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Capital Expenditure Over TimeExpanding
Percentile Rank50
Studio
Year-over-Year Change

Cash spent on acquiring or upgrading physical assets

Latest
$-1.13M
Near historical average
Percentile
P50
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-1.20M
Historical baseline
PeriodValueYoY Change
TTM$-1.13M+48.8%
2024$-2.21M-255.1%
2023$-621000.00+19.1%
2022$-768000.00+40.4%
2021$-1.29M-